Showing results (81-90 of 185) with videos related to

Sort By:
Pageof 19
Scandinavian Journal of Gastroenterology|August 1, 2022
End of induction patient reported outcomes predict clinical remission and endoscopic improvement with vedolizumab and adalimumab in ulcerative colitisEmily Chu Lee Wong, Badar Hasan, Parambir S Dulai, et al.
Inflammatory Bowel Diseases|November 25, 2022
Predictors of Clinical Remission to Placebo in Clinical Trials of Crohn's DiseaseEmily C L Wong, Parambir S Dulai, John K Marshall, et al.
Journal of Crohn'S & Colitis|August 12, 2025
Impact of Concomitant Corticosteroid Use on Adverse Events in Ulcerative Colitis Clinical TrialsHasan Hamam, Parambir S Dulai, John K Marshall, et al.
Inflammatory Bowel Diseases|December 30, 2021
Decision Support Tool Identifies Ulcerative Colitis Patients Most Likely to Achieve Remission With Vedolizumab vs AdalimumabParambir S Dulai, Emily C L Wong, Walter Reinisch, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 30, 2021
Comparative Efficacy for Infliximab Vs Vedolizumab in Biologic Naive Ulcerative ColitisNeeraj Narula, Emily C L Wong, John K Marshall, et al.
Journal of Crohn'S & Colitis|March 11, 2021
Outcomes of Passable and Non-passable Strictures in Clinical Trials of Crohn's Disease: A Post-hoc AnalysisNeeraj Narula, Emily C L Wong, Parambir S Dulai, et al.
Journal of Crohn'S & Colitis|September 15, 2020
Week 6 Calprotectin Best Predicts Likelihood of Long-term Endoscopic Healing in Crohn's Disease: A Post-hoc Analysis of the UNITI/IM-UNITI TrialsNeeraj Narula, Emily C L Wong, Parambir S Dulai, et al.
Alimentary Pharmacology & Therapeutics|June 6, 2019
Systematic review with meta-analysis: association between Helicobacter pylori CagA seropositivity and odds of inflammatory bowel diseaseAdam Tepler, Neeraj Narula, Richard M Peek, et al.
European Journal of Gastroenterology & Hepatology|August 17, 2021
Higher adalimumab maintenance regimen is more effective than standard dose in anti-TNF experienced Crohn's disease patientsTomer Greener, Karen Boland, Raquel Milgrom, et al.
Crohn'S & Colitis 360|October 28, 2024
Interventions for Adjunctive Care in Patients With Inflammatory Bowel Disease and Permanent Ileostomy: A Systematic ReviewSudheer Kumar Vuyyuru, Virginia Solitano, Yuhong Yuan, et al.
Pageof 19